DK3790548T3 - Fremgangsmåder til forbedring af biotilgængeligheden og eksponeringen af en åbner af spændingsstyret kaliumkanal - Google Patents

Fremgangsmåder til forbedring af biotilgængeligheden og eksponeringen af en åbner af spændingsstyret kaliumkanal Download PDF

Info

Publication number
DK3790548T3
DK3790548T3 DK19727216.4T DK19727216T DK3790548T3 DK 3790548 T3 DK3790548 T3 DK 3790548T3 DK 19727216 T DK19727216 T DK 19727216T DK 3790548 T3 DK3790548 T3 DK 3790548T3
Authority
DK
Denmark
Prior art keywords
bioavailability
exposure
improving
methods
potassium channel
Prior art date
Application number
DK19727216.4T
Other languages
English (en)
Inventor
Gregory N Beatch
Original Assignee
Xenon Pharmaceuticals Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Xenon Pharmaceuticals Inc filed Critical Xenon Pharmaceuticals Inc
Application granted granted Critical
Publication of DK3790548T3 publication Critical patent/DK3790548T3/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47—Quinolines; Isoquinolines
    • A61K31/472—Non-condensed isoquinolines, e.g. papaverine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/08—Antiepileptics; Anticonvulsants

Landscapes

  • Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Neurosurgery (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Pain & Pain Management (AREA)
  • Nutrition Science (AREA)
  • Physiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
DK19727216.4T 2018-05-11 2019-05-10 Fremgangsmåder til forbedring af biotilgængeligheden og eksponeringen af en åbner af spændingsstyret kaliumkanal DK3790548T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US201862670253P 2018-05-11 2018-05-11
PCT/US2019/031872 WO2019217924A1 (en) 2018-05-11 2019-05-10 Methods for enhancing the bioavailability and exposure of a voltage-gated potassium channel opener

Publications (1)

Publication Number Publication Date
DK3790548T3 true DK3790548T3 (da) 2023-11-13

Family

ID=66669101

Family Applications (1)

Application Number Title Priority Date Filing Date
DK19727216.4T DK3790548T3 (da) 2018-05-11 2019-05-10 Fremgangsmåder til forbedring af biotilgængeligheden og eksponeringen af en åbner af spændingsstyret kaliumkanal

Country Status (34)

Country Link
US (6) US11135214B2 (da)
EP (2) EP3790548B1 (da)
JP (3) JP7570924B2 (da)
KR (1) KR20210020892A (da)
CN (3) CN112384216A (da)
AU (2) AU2019265002C1 (da)
BR (1) BR112020022713A2 (da)
CA (1) CA3099292A1 (da)
CL (1) CL2020002932A1 (da)
CO (1) CO2020015476A2 (da)
CR (1) CR20200602A (da)
DK (1) DK3790548T3 (da)
EA (1) EA202092720A1 (da)
ES (1) ES2964409T3 (da)
FI (1) FI3790548T3 (da)
GE (2) GEP20237527B (da)
HR (1) HRP20231447T1 (da)
HU (1) HUE064326T2 (da)
IL (2) IL278577B2 (da)
LT (1) LT3790548T (da)
MA (1) MA52569B1 (da)
MD (1) MD3790548T2 (da)
MX (2) MX2020012008A (da)
MY (1) MY204915A (da)
PE (1) PE20211211A1 (da)
PH (1) PH12020551898A1 (da)
PL (1) PL3790548T3 (da)
PT (1) PT3790548T (da)
RS (1) RS64922B1 (da)
SG (1) SG11202011102TA (da)
SI (1) SI3790548T1 (da)
SM (1) SMT202300399T1 (da)
UA (1) UA127229C2 (da)
WO (1) WO2019217924A1 (da)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
MA52569B1 (fr) 2018-05-11 2023-11-30 Xenon Pharmaceuticals Inc Méthodes pour améliorer la biodisponibilité et l'exposition d'un activateur de canal potassique voltage-dépendant
TWI886158B (zh) 2019-10-10 2025-06-11 加拿大商再諾製藥公司 選擇性鉀通道調節劑之固態晶型
CA3155812A1 (en) 2019-11-08 2021-05-14 Cynthia Louise HARDEN Methods of treating depressive disorders
WO2021113757A1 (en) * 2019-12-06 2021-06-10 Xenon Pharmaceuticals Inc. Use of a kv7 potassium channel opener for treating pain
GEAP202416349A (en) * 2021-02-09 2024-02-12 Xenon Pharmaceuticals Inc Conjoint therapy for treating seizure disorders
TW202245744A (zh) 2021-02-09 2022-12-01 加拿大商再諾製藥公司 治療失樂症之方法及用途
CN113698345B (zh) * 2021-10-27 2022-02-01 上海挚盟医药科技有限公司 作为钾通道调节剂的化合物及其制备和应用
WO2026102345A1 (en) 2024-11-08 2026-05-15 Xenon Pharmaceuticals Inc. Methods of administering the voltage-gated potassium channel opener azetukalner

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8236861B2 (en) 2004-02-13 2012-08-07 Hormos Medical Corporation Method for enhancing the bioavailablity of ospemifene
US8119602B2 (en) 2005-06-02 2012-02-21 Schering Corporation Administration of HCV protease inhibitors in combination with food to improve bioavailability
EP2012769A1 (en) 2006-05-02 2009-01-14 Rundfeldt, Chris Potassium channel activators for the prevention and treatment of dystonia and dystonia-like symptoms
NZ575652A (en) 2006-08-23 2011-08-26 Valeant Pharmaceuticals Int Derivatives of 4-(n-azacycloalkyl) anilides as potassium channel modulators
US8993593B2 (en) * 2006-08-23 2015-03-31 Valeant Pharmaceuticals International N-(4-(6-fluoro-3,4-dihydroisoquinolin-2(1H)-yl)-2,6-dimethylphenyl)-3,3-dimethylbutanamide as potassium channel modulators
US20100323016A1 (en) * 2008-07-18 2010-12-23 Biljana Nadjsombati Modified release formulation and methods of use
CA2787247A1 (en) * 2010-01-20 2011-07-28 Glaxo Group Limited Novel composition
US10500216B2 (en) 2011-11-18 2019-12-10 Corcept Therapeutics, Inc. Optimizing mifepristone absorption
MA52569B1 (fr) 2018-05-11 2023-11-30 Xenon Pharmaceuticals Inc Méthodes pour améliorer la biodisponibilité et l'exposition d'un activateur de canal potassique voltage-dépendant

Also Published As

Publication number Publication date
JP2026048849A (ja) 2026-03-17
MY204915A (en) 2024-09-21
GEAP202315508A (en) 2023-04-25
CR20200602A (es) 2021-03-02
IL319015A (en) 2025-04-01
SMT202300399T1 (it) 2024-03-13
EA202092720A1 (ru) 2021-04-14
PE20211211A1 (es) 2021-07-05
CN120549930A (zh) 2025-08-29
US20250275957A1 (en) 2025-09-04
CO2020015476A2 (es) 2021-01-29
KR20210020892A (ko) 2021-02-24
AU2024219794A1 (en) 2024-10-10
EP4279133A2 (en) 2023-11-22
MD3790548T2 (ro) 2024-02-29
JP2021523130A (ja) 2021-09-02
GEP20237527B (en) 2023-08-10
WO2019217924A1 (en) 2019-11-14
MA52569B1 (fr) 2023-11-30
RS64922B1 (sr) 2023-12-29
MX2020012008A (es) 2021-04-12
EP3790548B1 (en) 2023-08-23
IL278577B2 (en) 2025-07-01
CL2020002932A1 (es) 2021-02-26
FI3790548T3 (fi) 2023-11-17
EP4279133A3 (en) 2024-02-21
MX2023013247A (es) 2023-11-21
ES2964409T3 (es) 2024-04-05
AU2019265002C1 (en) 2025-01-23
LT3790548T (lt) 2024-01-10
US20250221980A1 (en) 2025-07-10
US20240316032A1 (en) 2024-09-26
HRP20231447T1 (hr) 2024-03-01
US20190343823A1 (en) 2019-11-14
EP3790548A1 (en) 2021-03-17
JP7570924B2 (ja) 2024-10-22
SI3790548T1 (sl) 2024-02-29
AU2019265002A1 (en) 2020-12-03
BR112020022713A2 (pt) 2021-02-02
PT3790548T (pt) 2023-11-23
IL278577A (da) 2021-01-31
PL3790548T3 (pl) 2024-03-11
US11135214B2 (en) 2021-10-05
CN112384216A (zh) 2021-02-19
CN120549929A (zh) 2025-08-29
IL278577B1 (en) 2025-03-01
SG11202011102TA (en) 2020-12-30
PH12020551898A1 (en) 2021-07-12
UA127229C2 (uk) 2023-06-14
MA52569A (fr) 2021-03-17
US20220062266A1 (en) 2022-03-03
AU2019265002B2 (en) 2024-06-20
JP7793016B2 (ja) 2025-12-26
CA3099292A1 (en) 2019-11-14
HUE064326T2 (hu) 2024-03-28
JP2025011203A (ja) 2025-01-23
US20240316033A1 (en) 2024-09-26

Similar Documents

Publication Publication Date Title
DK3775909T3 (da) Midler og fremgangsmåder til glykoprofilering af et protein
EP3855818C0 (en) METHOD AND DEVICE FOR POSITIONING
DK3445068T3 (da) Fremgangsmåde til drift af et høreapparat og et høreapparat
DK3797182T3 (da) Elektrolyseenhed og fremgangsmåde til drift af elektrolyseenhed
DK3701973T3 (da) Plasmabaseret film og fremgangsmåder til fremstilling og anvendelse af samme
EP3849254A4 (en) POSITIONING PROCESS AND APPARATUS
DK3426859T3 (da) Gipspanel, anvendelse af et sådant panel og fremgangsmåde til fremstilling af et sådant panel
DK3874813T3 (da) Mobilitetsprocedure
DK3809724T3 (da) Fremgangsmåde til drift af et høreapparat og et høreapparat
DK3591222T3 (da) Vindmølle og fremgangsmåde til drift af en vindmølle
DK4434585T3 (da) Forbindelser og fremgangsmåder til reduktion af snca-ekspression
EP3897391C0 (en) ECHO-BASED FOCUS CORRECTION
DK3445067T3 (da) Fremgangsmåde til drift af et høreapparat og et høreapparat
DK3565276T3 (da) Fremgangsmåde til drift af et høreapparat og høreapparat
SG11202011102TA (en) Methods for enhancing the bioavailability and exposure of a voltage-gated potassium channel opener
DK3788802T3 (da) Fremgangsmåde til drift af et høreapparat og høreapparat
EP3845900A4 (en) CHROMATOGRAPHY KIT AND CHROMATOGRAPHY PROCEDURE
DK3355593T3 (da) Fremgangsmåde til drift af en hørehjælpeindretning og hørehjælpeindretning
DK3869952T3 (da) Intelligent fælde og forbrugsvarer
DK3898461T3 (da) Fremgangsmåde til anvendelse af en justeringsstation til skiver og en justeringsstation til udførelse af fremgangsmåden
DK3396024T3 (da) Elektrokemisk anordning og fremgangsmåde til drift af en elektrokemisk anordning
DK3396978T3 (da) Fremgangsmåde til drift af en høreindretning og en høreindretning
DK3788410T3 (da) Pneumatisk aktuator og fremgangsmåde til drift af en pneumatisk aktuator
EP3743172A4 (en) SINGLE SIDE SLED
DK3563064T3 (da) Piezohydraulisk aktuator og fremgangsmåde til drift af en sådan piezohydraulisk aktuator